How Tirzepatide Works

Tirzepatide is the first and only dual incretin agonist. It simultaneously stimulates GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This two-pathway approach amplifies satiety signals, slows gastric emptying, and improves insulin sensitivity—biological actions that reduce hunger, stabilize blood sugar, and accelerate fat loss. The result is a coordinated metabolic reset that helps patients achieve, on average, 20 % total body-weight reduction within 12 months.

Clinical Benefits

Dual-Action Mechanism

Activates both GLP-1 and GIP pathways for synergistic appetite suppression and energy expenditure.

20 % Average Body-Weight Loss

SURMOUNT-1 trial participants lost up to 22.5 % of baseline weight—superior to semaglutide trials.

Once-Weekly Injection

Pre-filled pen arrives at your door. Self-administer in seconds; no daily pills or complicated dosing.

FDA-Regulated Pharmacy

Compounded in an FDA-inspected, PCAB-accredited U.S. facility using the same active base as Mounjaro®.

Licensed Provider Care

Board-certified clinicians personalize every dose, monitor progress, and adjust therapy monthly.

Faster Results

Patients commonly notice reduced cravings within 7 days and measurable scale changes by week 4.

Semaglutide vs. Tirzepatide at a Glance

Attribute	Semaglutide (GLP-1 only)	Tirzepatide (GLP-1 + GIP)
Receptors Targeted	GLP-11	GLP-1 + GIP (dual)
Avg. Weight Loss (68-week data)	~15 %	~20 %
Time to 5 % Loss	12 weeks	8 weeks
HbA1c Reduction	1.5–1.8 %	2.0–2.4 %
Injection Frequency	Once weekly	Once weekly
Cost at Novolene	$249/mo	$299/mo

Transparent Pricing—All-Inclusive $299/Month

Comprehensive telehealth consult & prescription
Custom-compounded tirzepatide (4-week supply)
Supplies: alcohol swabs, syringes, sharps container
Free 2-day shipping
Unlimited messaging with your care team
Monthly dose titration & progress review

No insurance, no hidden consult fees, no no surprises.

What to Expect

Week 0: Complete online intake; provider reviews history within 24 h.
Week 1: Receive pen; start at 2.5 mg. Mild nausea possible—nurse hotline available.
Week 4: Check-in labs optional; dose may increase to 5 mg.
Week 8–12: Appetite noticeably smaller; average 6–8 % weight reduction.
Month 6: Target dose 10–15 mg; 15–18 % weight loss common.
Month 12: Maintenance plan; evaluate tapering options with clinician.

Frequently Asked Questions

Is compounded tirzepatide safe?: Yes. Our partner pharmacies source pharmaceutical-grade tirzepatide base and follow USP <797> sterile compounding standards. Every batch is third-party tested for potency and purity.
How quickly will I lose weight?: Most patients see measurable loss by week 4 and 10 % or more by month 4. Individual speed depends on dose titation, nutrition, and activity.
What are common side effects?: Mild nausea, constipation, or loose stools occur in 20–30 % of users, usually resolving within 1–2 weeks. Our clinical team provides diet and OTC remedies.
Do I have to follow a special diet?: No mandatory plan, but we recommend adequate protein (1 g/kg) and hydration to preserve lean mass and minimize GI upset.
Can I travel with the medication?: Yes. Pens are shipped in insulated packaging. Once opened, they remain stable for 28 days at room temperature (below 86 °F/30 °C).
What if I miss a dose?: Take the injection as soon as you remember within 4 days, then resume your regular schedule. If more than 4 days, skip and continue normally.
Is this the same as Mounjaro®?: Our compounded drug contains the same active ingredient (tirzepatide) but is formulated in a specialty pharmacy. It is not the Eli Lilly branded product.
How do I cancel?: Email care@novolene.com at least 7 days before your next refill. No long-term contract; restart anytime.

Compounded Tirzepatide: Dual-Action Weight Loss from $299/mo